Duncan Berry, MD
Ophthalmology · Charlotte, NCNPI 1326488560
Payments from drug & device makers
Across 21 payments — averaging $62.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$806
- Alcon$117
- Regeneron Healthcare Solutions, Inc.$112
- Genentech USA, Inc.$109
- Neurotech Pharmaceuticals, Inc.$30
- ANI Pharmaceuticals, Inc.$27
- plus $108 from 6 others
What the payments were for
- Travel & lodging$80662%
- Food & beverage$50338%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 2 | $806 |
| Alcon | 1 | $117 |
| Regeneron Healthcare Solutions, Inc. | 5 | $112 |
| Genentech USA, Inc. | 5 | $109 |
| Neurotech Pharmaceuticals, Inc. | 1 | $30 |
| ANI Pharmaceuticals, Inc. | 1 | $27 |
| Alimera Sciences, Inc. | 1 | $23 |
| AbbVie | 1 | $21 |
| Bausch & Lomb Americas Inc. | 1 | $19 |
| Biotissue Holdings Inc. | 1 | $16 |
| Optinose US, Inc. | 1 | $14 |
| Eyevance Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Luxor$117
- Constellation$117
How this compares
$1,309 in reported general payments places this provider in the 45th percentile of 588 ophthalmology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 169 | $6,059 |
| Ketorolac Tromethamine | 78 | $1,783 |
| Difluprednate | 14 | $1,542 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 78 | $1,111 |
| Timolol Maleate | 55 | $753 |
| Atropine Sulfate | 18 | $585 |
| Ciprofloxacin Hcl | 47 | $512 |
| Latanoprost | 80 | $394 |
| ErythromycinErythromycin Base | 33 | $326 |
| Dorzolamide Hcl | 11 | $200 |
| Brimonidine Tartrate | 32 | $191 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Charlotte
- Andrew AntoszykCharlotte$4M
- Omar PunjabiCharlotte$413K
- Thomas MundorfCharlotte$288K
- John AllenCharlotte$122K
- Sheila Garcia-SantanaCharlotte$60K
- David BrowningCharlotte$59K
- Glenn JaffeDurham$38.5M
- Lejla VajzovicDurham$7.5M
- Majda HadziahmetovicDurham$2.4M
- Preeya GuptaRaleigh$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.